marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Yumanity Therapeutics Income Statement 2011-2024 | YMTX
Annual Income Statement Yumanity Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
17.6 M | 7.83 M | 8.5 M | 181 M | 341 M | - | - | - | - | - | - | - | - |
Shares |
11.1 M | 4.93 M | 4.36 M | 10.1 M | 10.1 M | - | - | - | - | - | - | - | - |
Historical Prices |
1.59 | 1.59 | 1.95 | 17.9 | 33.4 | 60.4 | 92.6 | 295 | - | - | - | - | - |
Net Income |
-14.1 M | -63.4 M | -11.8 M | -57.5 M | -31.2 M | - | - | - | - | - | - | - | - |
Revenue |
5.44 M | 1.95 M | 9.09 M | 3 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-15.7 M | -41.5 M | -11.1 M | -55.6 M | -30 M | -63.2 M | -60 M | -37.5 M | -24.5 M | -15.7 M | - | - | - |
Interest Expense |
337 K | 3.74 M | 1.29 M | 1.9 M | 1.21 M | 478 K | -100 K | -23 K | 599 K | 199 K | - | - | - |
EBITDA |
-15.7 M | -41.5 M | -11 M | -54.9 M | -28.4 M | - | - | - | - | - | - | - | - |
Operating Expenses |
21.2 M | 43.5 M | 20.2 M | 62.5 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.1 M | 8.7 M | 4.62 M | 11.9 M | 7.06 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Yumanity Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
13.4 M | 13.1 M | 11.4 M | 10.4 M | 11.7 M | 9.94 M | 8.36 M | 8.32 M | 4.89 M | 4.8 M | 4.66 M | 10.6 M | 10.3 M | 10.2 M | 10.2 M | 10.2 M | 2.16 M | 2.16 M | 2.15 M | 51.4 M | 51.1 M | 51.1 M | 51 M | 46.7 M | 36.7 M | 36 M | 34.5 M | 26.5 M | 25.1 M | 25 M | 25 M | 25 M | 20.1 M | 19.1 M | 10.8 M | 569 K | 557 K | 554 K | 533 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.78 M | -2.6 M | -10.2 M | - | -5.38 M | 386 K | -6.45 M | - | -5.58 M | -5.88 M | -4.98 M | - | -9.96 M | -10.5 M | -8.68 M | - | -6.38 M | -6.97 M | -7.46 M | -11.9 M | -12.8 M | -20 M | -14.4 M | -16.9 M | -18.4 M | -15.5 M | -11 M | -13.4 M | -14 M | -17 M | -15.1 M | -9.42 M | -10.8 M | -9.05 M | -7.99 M | -5.63 M | -7.05 M | -6.62 M | -5.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | 5.16 M | 281 K | - | 200 K | 833 K | 433 K | - | 1.64 M | 2.11 M | 3.53 M | - | 3.31 M | - | - | - | 5 M | 5 M | 5 M | - | 1.06 M | 843 K | 942 K | 1.62 M | 1.55 M | 1.15 M | 1.02 M | 4.06 M | 1.72 M | 20 K | 1.16 M | 1.23 M | 1.2 M | 1.07 M | 807 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.06 M | -2.59 M | -6.41 M | - | -3.99 M | -980 K | -6.49 M | - | -4.45 M | -4.87 M | -5.2 M | - | -9.5 M | -9.92 M | -9.3 M | - | -5.91 M | -6.54 M | -7.06 M | -12.2 M | -13.3 M | -20.6 M | -15.1 M | -17.5 M | -18.7 M | -15.7 M | -11.3 M | -13.5 M | -14.1 M | -17.1 M | -15.3 M | -9.6 M | -10.8 M | -9.07 M | -8.02 M | -6.32 M | -6.58 M | -6.62 M | -5.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-4 K | 32 K | 42 K | - | -3 K | 21 K | 23 K | - | 559 K | 556 K | 584 K | - | 454 K | 463 K | 488 K | - | 501 K | 455 K | 454 K | 86 K | 242 K | 292 K | 316 K | 255 K | 87 K | 46 K | 90 K | -43 K | -25 K | -2 K | -30 K | -8 K | -38 K | -5 K | 28 K | 691 K | 189 K | 209 K | 201 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -3.98 M | -978 K | -6.48 M | - | -4.44 M | -4.85 M | -5.18 M | - | -8.99 M | -9.92 M | -9.1 M | - | -5.33 M | -6.15 M | -6.86 M | -12.2 M | -13.1 M | -20.5 M | -14.7 M | -17.5 M | -17.3 M | -14.6 M | -10.7 M | -13.5 M | -13.1 M | -16.4 M | -14.9 M | -9.6 M | -10.5 M | -8.93 M | -7.95 M | -6.32 M | -6.38 M | -6.49 M | -4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.06 M | 2.59 M | 6.41 M | - | 3.99 M | 6.14 M | 6.77 M | - | 4.65 M | 5.7 M | 5.63 M | - | 11.1 M | 12 M | 12.8 M | - | 9.21 M | 6.54 M | 7.06 M | 12.2 M | 13.3 M | 20.6 M | 20.1 M | 17.5 M | 19.7 M | 16.6 M | 12.2 M | 15.1 M | 15.6 M | 18.3 M | 16.3 M | 13.7 M | 12.5 M | 10.5 M | 9.18 M | 7.56 M | 7.78 M | 7.68 M | 5.82 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.16 M | 1.59 M | 3.68 M | - | 2.08 M | 3.43 M | 3.92 M | - | 2.05 M | 1.82 M | 1.61 M | - | 4.51 M | 4.71 M | 6.05 M | - | 3.72 M | 2.6 M | 2.03 M | 3.06 M | 3.15 M | 3.68 M | 3.94 M | 3.78 M | 4.15 M | 3.96 M | 3.82 M | 2.85 M | 2.74 M | 2.9 M | 3.17 M | 3.2 M | 3.27 M | 3.12 M | 2.3 M | 1.77 M | 1.52 M | 1.71 M | 1.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency